What Makes Us Different And Better

Our solution integrates an innovative technology that is patented to ensure its uniqueness. In addition, it has been validated by a clinical trial with 100 patients, and incorporates a regulatory approach in order to differentiate from a simple electronic gadget, and a big-data value (valuable information for industry and doctors). Moreover, our solution can be easily adapted to other conditions than anaphylaxis.

PATENT NUMº US 2018 / 0061208 A1

Our Story

Adan Medical Innovation was born in July 2013 between Silicon Valley and Barcelona. The idea became a reality during an Innovation program (Imagine Creativity Center) in Silicon Valley, were the co-founders Anna Sala and Adrian Curran reframed all the concerns that the patients who suffer allergic reactions have and prototyped the idea, defining the next steps. The first thing was to put together an appropriate team, with the main aim of “improving the quality of life of patients that suffer anaphylaxis”.

“If you want to go fast go alone, but if you want to go far go together “. With this in mind, Adan Medical Innovation wanted to be a different health tech company, and created a multidisciplinary team with experts in all the different areas that the project needed (clinical, regulatory, hardware&software, quality control, design…), also including patients, to be able to bring excellence to the project.

During these years, the team has grown and worked very hard, always with the purpose to improve the development of our solution. The first clinical trial with a device evaluating its usefulness for the management of anaphylaxis has been completed in one of the largest hospitals in Europe. Currently, with the improved solution and the clinical trial completed, we are working on the last steps to bring anAPPhylaxis to the market, which involve regulatory clearance. In addition, we are also working with new technologies to bring our solution to public spaces using IOT, to be able to improve the quality of life of all potential patients and increase the awareness and knowledge of the disease around the world.

OUR PURPOSE

Our mission is to improve the quality of life of patients that suffer severe allergic reactions requiring epinephrine. To achieve this we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients amongst us, and we are working together to offer the best solutions for these patients.

CEO

With a long management career in healthcare companies and expert in developing technological projects in e-Health industry: ClinicalSession, Abanden Telehealth and BioPhysiotherapy.

PhD. Chairman

Industry specialist, he has led the discovery and development of new treatments in the biopharmaceutical industry in USA, with three drugs approved and two Phase III, plus two medical devices marketed.

M.D, PhD, Co-Founder
& Medical Director

Allergy specialist in Vall d’Hebron Hospital. Associate Prof. of Inmunology. Member of the World Allergy Organization and the European Academy of Allergy and Clinical Immunology and different Cientific Committee with more than 35 indexed international papers.

M.D, PhD. Co-Founder
& Medical Advisor

Internal Medicine specialist in Vall d’Hebron Hospital. acts as an advisor for different pharmaceutical companies and has more than 70 indexed international papers.

CTO

Electronics engineer with more than 10 years of experience in design, development and technical coordination of research and innovation projects.

Advisor

Entrepreneur from Barcelona based in Silicon Valley who, in the past 16 years, has launched several technological innovation companies, such as TMT Factory or Innovalley.

PhD. Chief Business Officer

With more than 30 years of experience in the pharmaceutical/biotechnology sector, starting with Celltech, Daiichi Sankyo Pharmaceuticals in Japan, and SafePharm Laboratories in the UK.

Program Manager

Biotechnologist with a vast background in fundraising of biotech and pharma sector StartUps, project management and implementation of business strategies.